| Joan Mitchell, ST | |
|
512 E Three Notch St, Andalusia, AL 36420-3128 | |
| (334) 222-2102 | |
| Not Available |
| Full Name | Joan Mitchell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 512 E Three Notch St, Andalusia, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609935170 | NPI | - | NPPES |
| 1072 | Other | AL | SLP LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1072 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joan Mitchell, ST 111 Ridgecrest Dr, Andalusia, AL 36421-4226 Ph: (334) 222-8463 | Joan Mitchell, ST 512 E Three Notch St, Andalusia, AL 36420-3128 Ph: (334) 222-2102 |
News Archive
The U.S. Census Bureau will hold an online news conference to announce the findings from its annual report: Income, Poverty, and Health Insurance Coverage in the United States: 2008. This report contains the official national findings from the Current Population Survey (CPS).
A team of scientists led by The New York Stem Cell Foundation Research Institute successfully created a human stem cell disease model of Parkinson's disease in a dish. Studying a pair of identical (monozygotic) twins, one affected and one unaffected with Parkinson's disease, another unrelated Parkinson's patient, and four healthy control subjects, the scientists were able to observe key features of the disease in the laboratory, specifically differences in the patients' neurons' ability to produce dopamine, the molecule that is deficient in Parkinson's disease.
Agilent Technologies Inc. (NYSE:A) has announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. The change in structure reflects the growth opportunities of each business and supports Agilent's continued evolution as a leading bio-analytical company.
A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
› Verified 8 days ago
Lindsey Crutchfield, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28701 Nalls Rd, Andalusia, AL 36421 Phone: 334-488-6729 | |
Speech Therapy Of Andalusia Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1517b E Three Notch St, Andalusia, AL 36420 Phone: 334-803-2933 Fax: 833-975-0983 |